New Cancer Treatment Shows 100% Success Rate In Tough Lymphoma Cases, Say Scientists
A new Brazilian-developed CAR-T cell therapy has shown extraordinary results in treating refractory CD30+ lymphoma, including complete remission in half of the trial patients.
Apr 29, 2025, 20:32 PM IST